Ozempic Archives - Express Pharma

Cardiovascular benefits can increase Rybelsus’ competitiveness over other oral GLP-1RAs

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug

Ozempic linked with lower dementia risk, nicotine use, British study finds

WHO issues warnings on fake copies of Novo Nordisk’s weight-loss drugs

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData

US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes

Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData

T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029